GPT Healthcare Limited (NSE:GPTHEALTH)
India · Delayed Price · Currency is INR 133.00
-2.68 (-1.98%)
Oct 22, 2026, 3:30 PM IST
GPT Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 10,958 | 9,462 | 12,060 | 14,466 | - | - | |
Market Cap Growth | -10.36% | -21.54% | -16.64% | - | - | - |
Enterprise Value | 11,398 | 10,098 | 12,133 | 15,096 | - | - |
Last Close Price | 133.55 | 114.28 | 143.28 | 168.43 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 23.12 | 22.41 | 24.16 | 30.28 | - | - |
Forward PE | - | 16.65 | 19.09 | - | - | - |
PS Ratio | 2.23 | 2.00 | 2.96 | 3.62 | - | - |
PB Ratio | 4.07 | 3.51 | 4.87 | 6.62 | - | - |
P/TBV Ratio | 4.07 | 3.52 | 4.89 | 6.65 | - | - |
P/FCF Ratio | 27.85 | 24.05 | 69.03 | 29.26 | - | - |
P/OCF Ratio | 13.50 | 11.66 | 17.89 | 21.03 | - | - |
PEG Ratio | - | 0.80 | 0.99 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.32 | 2.14 | 2.98 | 3.77 | - | - |
EV/EBITDA Ratio | 12.40 | 13.47 | 15.74 | 18.15 | - | - |
EV/EBIT Ratio | 17.67 | 17.30 | 18.86 | 21.46 | - | - |
EV/FCF Ratio | 28.97 | 25.67 | 69.45 | 30.54 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.34 | 0.34 | 0.14 | 0.14 | 0.50 | 0.64 |
Debt / EBITDA Ratio | 0.99 | 1.07 | 0.43 | 0.35 | 1.12 | 1.37 |
Debt / FCF Ratio | - | 2.32 | 2.02 | 0.62 | 1.47 | 1.73 |
Net Debt / Equity Ratio | 0.16 | 0.16 | 0.00 | 0.05 | 0.40 | 0.56 |
Net Debt / EBITDA Ratio | 0.54 | 0.59 | -0.01 | 0.14 | 0.92 | 1.21 |
Net Debt / FCF Ratio | - | 1.12 | -0.06 | 0.23 | 1.17 | 1.50 |
Asset Turnover | - | 1.11 | 1.12 | 1.19 | 1.11 | 1.05 |
Inventory Turnover | - | 18.88 | 18.04 | 17.53 | 16.96 | 20.35 |
Quick Ratio | - | 0.93 | 0.83 | 0.65 | 0.58 | 0.48 |
Current Ratio | - | 1.12 | 1.06 | 1.04 | 0.99 | 1.25 |
Return on Equity (ROE) | - | 16.32% | 21.41% | 24.89% | 24.11% | 28.53% |
Return on Assets (ROA) | - | 8.60% | 11.02% | 13.08% | 11.43% | 11.80% |
Return on Invested Capital (ROIC) | 15.98% | 16.06% | 19.43% | 21.41% | 17.35% | 18.60% |
Return on Capital Employed (ROCE) | - | 15.20% | 20.70% | 26.20% | 24.30% | 23.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.33% | 4.46% | 4.14% | 3.30% | - | - |
FCF Yield | 3.59% | 4.16% | 1.45% | 3.42% | - | - |
Dividend Yield | 1.88% | 2.17% | 1.70% | 1.42% | - | - |
Payout Ratio | 43.45% | 48.59% | 57.53% | 50.18% | 81.94% | 41.42% |
Buyback Yield / Dilution | -0.32% | - | -2.44% | -0.24% | - | - |
Total Shareholder Return | 1.56% | 2.17% | -0.74% | 1.18% | - | - |